|
The purpose of this
experience study is to determine if the above mentioned product can reduce
or eliminate snoring.
We have focused on diabetes patients, family members, and medical
professionals based on information from an article in the
American Journal of Epidemiology Vol. 155, No. 5 : 387-393, which stated, “Snoring is
independently associated with the elevated risk of Type 2 Diabetes.”
In addition recent research and anecdotal evidence has shown that
interruption of normal sleep patterns can cause disruptions in early morning
glucose levels.
This Experience study is not being used to evaluate changes in blood glucose
readings and does not require any extra testing.
The Experience Study will
evaluate the effectiveness of the SnoreQuell product in decreasing or
eliminating snoring. This will be determined by comparing before and after
questionnaires to be completed by each participant.
See Initial Survey Form Here
See Follow-up Survey Form Here
This study will last for 30 days.
If a significant number of participants have positive results, we will
conclude that this product is effective in reducing or eliminating snoring.
Registration:
At this time we are seeking medical professionals who
will administer the product to 5 participants including themselves, patients
or partners of patients. Fill out the form below to enroll.
(if you are not a medical professional and wish to participate, please
email us at diabetes@tampabay.rr.com ) |